The aim of this study was to determine how varying the dose of spinal amethocaine influences the incidence of visceral pain associated with exteriorization of the uterus after delivery. In a double-blind study, we examined the incidence of visceral pain in 40 parturients undergoing Caesarean section under spinal anaesthesia with amethocaine 8, 10, 12 or 14 mg in 2 ml of 5 % glucose. The dose of spinal amethocaine was found to influence the incidence of visceral pain associated with exteriorization of the uterus after delivery. The incidence of visceral pain was lower in the 12-mg (P : 0.05) and 14-mg (P : 0.01) groups than in the 8-mg group, although there were no differences in maximum spread of analgesia and circulatory changes between the four groups. This study suggests that a slightly higher dose of spinal amethocaine (12-14 mg) is preferable for Caesarean section. (Br.
The later stages of pregnancy are associated with enhanced spread of spinal anaesthesia so that the dose of spinal anaesthetic required to achieve a given level of analgesia is lower in parturients than in nonpregnant patients [1, 2] . Although a relatively low dose of spinal amethocaine in parturients (7-10 mg) results in adequate levels of analgesia for Caesarean section [3, 4] , many mothers complain of a poorly localized, dull pain when the uterus is exteriorized after delivery. The dose of spinal amethocaine is thought to influence not only the level of sensory block but also the quality of anaesthesia. The present study was designed therefore, to determine how varying the dose of spinal amethocaine (8-14 mg) influences the incidence of visceral pain during Caesarean section.
Patients and methods
We studied 40 parturients, ASA I-II, aged 26-39 yr, undergoing elective Caesarean section. After approval by the Hospital Ethics Committee, informed consent was obtained from all patients. No patient had any contraindications to spinal anaesthesia.
None of the patients was premedicated. Lactated Ringer's solution 1000 ml was given i.v. before anaesthesia. Patients were placed in the lateral position on a horizontal operating table. Under aseptic conditions, lumbar puncture was performed at the L3-4 interspace with a 25-gauge Quincke needle using a median approach. The needle was inserted with its bevel parallel to the dural fibres and then rotated 90° to direct the bevel cephalad. The correct position of the needle was confirmed by aspiration and reinjection of 0.1 ml of CSF before and after administration of the drug. The patients were allocated randomly to four groups to receive 8 mg (0.4 %), 10 mg (0.5 %), 12 mg (0.6 %) or 14 mg (0.7 %) of amethocaine in 2 ml of 5 % glucose. An assistant who did not participate in the anaesthetic management prepared the test solution in a sterile syringe immediately before injection by dissolving a crystalline preparation (Tetocaine for injection 20 mg, Kyorin Pharmaceutical Co., Ltd, Tokyo, Japan). The test solution was administered slowly over 40 s. Immediately after spinal injection, the patients were turned gently to the supine horizontal position. The uterus was displaced manually to the left side until the beginning of operation. No attempt was made to influence the level of spinal anaesthesia by positioning the operating table.
The spread of analgesia was assessed by pinprick bilaterally at 5, 10, 15, 20, 30 and 60 min after spinal injection according to a dermatomal chart [5] . If the analgesic levels of both sides differed, the average value was used for analysis. Motor block was assessed by modified Bromage score (0 ϭ ability to raise extended leg; 1 ϭ inability to raise extended leg; 2 ϭ inability to flex the knee; 3 ϭ inability to flex the ankle) at the intervals mentioned above.
All patients were asked several times about unpleasant feelings, pain, or both. Visceral pain was assessed on a five-point scale: (a) excellent, no complaints; (b) mild discomfort, requiring no supplementary analgesia; (c) intermediate discomfort accompanied by nausea, requiring supplementary droperidol 2.5 mg i.v.; (d) severe discomfort accompanied by pain, requiring buprenorphine 0.1-0.2 mg i.v.; and (e) failed, requiring general anaesthesia. All assessments were performed by an investigator who was blinded to the dose injected.
Arterial pressure and heart rate were measured by automatic sphygmomanometry at 1-min intervals until delivery and every 5 min thereafter. Lactated YOSHIHIRO Ringer's solution 600-800 ml was infused until the baby was delivered. Prophylactic ephedrine 10 mg i.v. was given to all patients immediately after spinal injection to maintain a stable arterial pressure. Additional i.v. ephedrine was given if systolic arterial pressure decreased to less than 100 mm Hg. Data between groups were compared using ANOVA followed by the Scheffé F test for parametric data, and the Kruskal-Wallis followed by the Mann-Whitney U test for non-parametric data. P : 0.05 was considered to be significant.
Results
There were no significant differences between the four groups in age, height, weight or gestational period (table 1). The spread of analgesia in all patients was almost comparable ( fig. 1 ). There were no differences in maximum spread of analgesia, time to maximum spread of analgesia, and time from spinal injection to total motor block in the legs (table  2) .
The dose of spinal amethocaine influenced the incidence of visceral pain associated with exteriorization of the uterus after delivery (table 3). The incidence of visceral pain was lower in the 12-mg and 14-mg groups than in the 8-mg group. There was no statistical difference between the 12-mg and 14-mg groups (P ϭ 0.054).
There were no differences in maximum changes in systolic, diastolic and mean arterial pressures, and no difference in heart rate between the four groups. The cumulative dose of ephedrine to treat maternal hypotension did not differ (table 4).
Discussion
We have found that the dose of spinal amethocaine influenced the incidence of visceral pain associated with exteriorization of the uterus after delivery. Although the dermatomal level of analgesia was almost the same between the four groups, we found that the higher dose of amethocaine (12-14 mg) reduced the incidence of visceral pain. Changes in cardiovascular indices after spinal injection did not differ between the four groups. These results suggest that a slightly higher dose of spinal amethocaine (12-14 mg) is preferable for Caesarean section because it provides better intraoperative analgesia without excessive spread of the spinal block. The qualities of visceral pain differ from those of somatic pain. Visceral pain is dull, poorly localized and appears to emanate from deep sites of the body. If visceral sensations remain, they may be described as heaviness, squeezing or an unpleasant feeling, which is often accompanied by nausea and vomiting. It is generally accepted that sensory analgesia to at least the fourth thoracic dermatome is necessary for Caesarean section. However, even with this level of sensory analgesia, many mothers complain of unpleasant feelings associated with exteriorization of the uterus after delivery [6] .
Visceral pain is believed to be transmitted by unmyelinated C fibres. It was postulated recently that with a declining concentration of local anaesthetic in CSF, unmyelinated C fibres may become unblocked, although conduction in myelinated Adelta fibres transmitting incisional pain has not been restored [7] . In this study, the incidence of visceral pain varied according to the dose of amethocaine injected. We speculate that low concentrations of amethocaine in the upper thoracic segments may promote selective block of A-delta fibres without concomitant block of C fibres. In contrast, a high dose of amethocaine, by pooling in the upper thoracic segments, may produce potent sensory block.
Our results are similar to those of Pedersen and colleagues who studied the incidence of visceral pain during Caesarean section with hyperbaric bupivacaine [8] . They reported that increasing the dose of bupivacaine from 7.5 to 12.5 mg reduced visceral pain from 70.5 % to 31.6 %, but did not affect spread of sensory analgesia. We suggest therefore, that our conclusions may be applied to all hyperbaric local anaesthetic solutions.
Pan and colleagues [9] studied the quality of anaesthesia during Caesarean section and reported that 15-18 mg of spinal amethocaine produced better intraoperative conditions, than 9-12 mg. However, they stated that the use of 18 mg of spinal amethocaine may be seldom indicated because of excessive spread.
This study was performed in parturients of Japanese origin who were all of relatively small stature and weight compared with patients of European or North American origin. The results of this study can be applied directly only to patients of the same race and within the age, height and weight ranges of the patients in this study.
The pain associated with exteriorization of the uterus after delivery is widely recognized, and in many obstetric units this practice is no longer routine. However, this manoeuvre is considered necessary in some clinical situations. In our study the manoeuvre was applied to all patients in order to assess the incidence of visceral pain under standard conditions. 
